Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹3,154.60
Market cap: ₹25,827 Cr
Revenue (annual): ₹1,339 Cr
Net profit (annual): ₹356.3 Cr
P/E (TTM): 66.9×Sector 47.4×
Promoter holding: 32.66%+0.00% QoQ
FII holding: 21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

24 Sep 2026 19:36 IST BSE

Acutaas Chemicals Merger & Restructuring Worth ₹0.01 Cr

Acutaas Chemicals will acquire 100% equity stake in step-down subsidiary Enchem Ami Organics for Rs. 1 Lakh, making it a direct wholly-owned subsidiary.

Value: ₹0.01 Cr
Execution: within one month

Read the filing ↗

19 May 2026 19:03 IST NSE

Merger & Restructuring

Acutaas Chemicals Merger & Restructuring Worth ₹5.83 Cr

Acutaas Chemicals Limited's subsidiary ACEPL issued shares to A.R.Z Pharma Ltd for ₹5.83 Crore. Consequently, the parent's stake in ACEPL reduced from 100% to 90%.

Value: ₹5.83 Cr

Read the filing ↗

19 May 2026 18:16 IST BSE

Merger & Restructuring

Acutaas Chemicals Merger & Restructuring Worth ₹5.83 Cr

Acutaas Chemicals Ltd subsidiary ACEPL allotted shares worth ₹5.83 Crore to A.R.Z Pharma Ltd. Consequently, ACEPL ceased being wholly-owned, with the parent's stake diluting to 90%.

Value: ₹5.83 Cr

Read the filing ↗